Impact of clinical severity index, infective pathogens, and initial empiric antibiotic use on hospital mortality in patients with ventilator-associated pneumonia

American Journal of Infection Control

Volumn 40, Issue 7, 2012, Pages 648-652

  Tseng, Chia Cheng ^a,b   Liu, Shih Feng ^a   Wang, Chin Chou ^a,b   Tu, Mei Lien ^a,b   Chung, Yu Hsiu ^a   Lin, Meng Chih ^a,b,c   Fang, Wen Feng ^a,b  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b CHANG GUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^c XIAMEN CHANG GUNG HOSPITAL   (China)

Author keywords

Appropriate antibiotic; Multi drug resistant strain; Oxygen index; SOFA score

Indexed keywords

AMINOGLYCOSIDE; BETA LACTAM; BETA LACTAMASE INHIBITOR; CARBAPENEM; QUINOLONE;

ACINETOBACTER BAUMANNII; ADULT; AGED; ANTIBIOTIC THERAPY; APACHE; ARTICLE; CHARLSON COMORBIDITY INDEX; COMORBIDITY; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; INFECTION RISK; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MORTALITY; OXYGENATION; OXYGENATION INDEX; PNEUMONIA SEVERITY INDEX; SCORING SYSTEM; SEPTIC SHOCK; SEQUENTIAL ORGAN FAILURE ASSESSMENT; TAIWAN; TRACHEOSTOMY; VENTILATOR ASSOCIATED PNEUMONIA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTERIA; COMORBIDITY; DRUG RESISTANCE, BACTERIAL; FEMALE; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; PNEUMONIA, VENTILATOR-ASSOCIATED; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TAIWAN; YOUNG ADULT;

EID: 84865797896     PISSN: 01966553     EISSN: 15273296     Source Type: Journal    
DOI: 10.1016/j.ajic.2011.08.017     Document Type: Article

References (31)

1. D.K. Heyland, D.J. Cook, L. Griffith, S.P. Keenan, and C. Brun-Buisson The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient. The Canadian Critical Trials Group Am J Respir Crit Care Med 159 1999 1249 1256
2. P. Jimenez, A. Torres, R. Rodriguez-Roisin, J.P. de la Bellacasa, R. Aznar, and J.M. Gatell Incidence and etiology of pneumonia acquired during mechanical ventilation Crit Care Med 17 1989 882 885
3. J. Rello, E. Quintana, V. Ausina, J. Castella, M. Luquin, and A. Net Incidence, etiology, and outcome of nosocomial pneumonia in mechanically ventilated patients Chest 100 1991 439 444
4. J.Y. Fagon, J. Chastre, A. Vuagnat, J.L. Trouillet, A. Novara, and C. Gibert Nosocomial pneumonia and mortality among patients in intensive care units JAMA 275 1996 866 869
5. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia Am J Respir Crit Care Med 171 2005 388 416
6. L. Lorente, S. Blot, and J. Rello New issues and controversies in the prevention of ventilator-associated pneumonia Am J Respir Crit Care Med 182 2010 870 876
7. M. Iregui, S. Ward, G. Sherman, V.J. Fraser, and M.H. Kollef Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia Chest 122 2002 262 268
8. C.M. Luna, P. Aruj, M.S. Niederman, J. Garzon, D. Violi, and A. Prignoni Appropriateness and delay to initiate therapy in ventilator-associated pneumonia Eur Respir J 27 2006 158 164
9. S. Nseir, C. Di Pompeo, P. Pronnier, S. Beague, T. Onimus, and F. Saulnier Nosocomial tracheobronchitis in mechanically ventilated patients: incidence, aetiology and outcome Eur Respir J 20 2002 1483 1489
10. A. Torres, R. Aznar, J.M. Gatell, P. Jimenez, J. Gonzalez, and A. Ferrer Incidence, risk, and prognosis factors of nosocomial pneumonia in mechanically ventilated patients Am Rev Respir Dis 142 1990 523 528
11. J. Rello, V. Ausina, M. Ricart, J. Castella, and G. Prats Impact of previous antimicrobial therapy on the etiology and outcome of ventilator-associated pneumonia. 1993 Chest 136 2009 e30
12. S. Nseir, C. Di Pompeo, S. Soubrier, B. Cavestri, E. Jozefowicz, and F. Saulnier Impact of ventilator-associated pneumonia on outcome in patients with COPD Chest 128 2005 1650 1656
13. C.M. Luna, P. Vujacich, M.S. Niederman, C. Vay, C. Gherardi, and J. Matera Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia Chest 111 1997 676 685
14. M.S. Niederman De-escalation therapy in ventilator-associated pneumonia Curr Opin Crit Care 12 2006 452 457
15. M.E. Charlson, P. Pompei, K.L. Ales, and C.R. MacKenzie A new method of classifying prognostic comorbidity in longitudinal studies: development and validation J Chronic Dis 40 1987 373 383
16. I.I. Siempos, K.Z. Vardakas, C.E. Kyriakopoulos, T.K. Ntaidou, and M.E. Falagas Predictors of mortality in adult patients with ventilator-associated pneumonia: a meta-analysis Shock 33 2010 590 601
17. G. Gursel, and S. Demirtas Value of APACHE II, SOFA and CPIS scores in predicting prognosis in patients with ventilator-associated pneumonia Respiration 73 2006 503 508
18. D. Trachsel, B.W. McCrindle, S. Nakagawa, and D. Bohn Oxygenation index predicts outcome in children with acute hypoxemic respiratory failure Am J Respir Crit Care Med 172 2005 206 211
19. O. Gajic, B. Afessa, B.T. Thompson, F. Frutos-Vivar, M. Malinchoc, and G.D. Rubenfeld Prediction of death and prolonged mechanical ventilation in acute lung injury Crit Care 11 2007 R53
20. N.G. Tornieporth, R.B. Roberts, J. John, A. Hafner, and L.W. Riley Risk factors associated with vancomycin-resistant Enterococcus faecium infection or colonization in 145 matched case patients and control patients Clin Infect Dis 23 1996 767 772
21. A.R. Naylor, P.D. Hayes, and S. Darke A prospective audit of complex wound and graft infections in Great Britain and Ireland: the emergence of MRSA Eur J Vasc Endovasc Surg 21 2001 289 294
22. J. Baillargeon, M.F. Kelley, C.T. Leach, G. Baillargeon, and B.H. Pollock Methicillin-resistant Staphylococcus aureus infection in the Texas prison system Clin Infect Dis 38 2004 e92 e95
23. H.F. Chambers The changing epidemiology of Staphylococcus aureus? Emerg Infect Dis 7 2001 178 182
24. M.S. Terpenning, S.F. Bradley, J.Y. Wan, C.E. Chenoweth, K.A. Jorgensen, and C.A. Kauffman Colonization and infection with antibiotic-resistant bacteria in a long-term care facility J Am Geriatr Soc 42 1994 1062 1069
25. A. Michalopoulos, and M.E. Falagas Treatment of Acinetobacter infections Expert Opin Pharmacother 11 2010 779 788
26. J. Garnacho-Montero, T. Aldabo-Pallas, C. Garnacho-Montero, A. Cayuela, R. Jimenez, and S. Barroso Timing of adequate antibiotic therapy is a greater determinant of outcome than are TNF and IL-10 polymorphisms in patients with sepsis Crit Care 10 2006 R111
27. F. Michel, B. Franceschini, P. Berger, J.M. Arnal, M. Gainnier, and J.M. Sainty Early antibiotic treatment for BAL-confirmed ventilator-associated pneumonia: a role for routine endotracheal aspirate cultures Chest 127 2005 589 597
28. R. Ramphal Importance of adequate initial antimicrobial therapy Chemotherapy 51 2005 171 176
29. M. Zaidi, J. Sifuentes-Osornio, A.L. Rolon, G. Vazquez, R. Rosado, and M. Sanchez Inadequate therapy and antibiotic resistance: risk factors for mortality in the intensive care unit Arch Med Res 33 2002 290 294
30. N. Bercault, and T. Boulain Mortality rate attributable to ventilator-associated nosocomial pneumonia in an adult intensive care unit: a prospective case-control study Crit Care Med 29 2001 2303 2309
31. R.M. Mera, L.A. Miller, H. Amrine-Madsen, and D.F. Sahm Acinetobacter baumannii 2002-2008: increase of carbapenem-associated multiclass resistance in the United States Microb Drug Resist 16 2010 209 215